Evolus Inc EOLS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 10:18 AM EDT
9.09quote price arrow up+0.14 (+1.56%)
Volume
94,713
52 week range
5.06 - 14.34
Loading...
  • Open9.09
  • Day High9.25
  • Day Low9.02
  • Prev Close8.95
  • 52 Week High14.34
  • 52 Week High Date05/17/22
  • 52 Week Low5.06
  • 52 Week Low Date01/24/22

Key Stats

  • Market Cap509.86M
  • Shares Out56.09M
  • 10 Day Average Volume0.97M
  • Dividend-
  • Dividend Yield-
  • Beta1.96
  • YTD % Change39.02

KEY STATS

  • Open9.09
  • Day High9.25
  • Day Low9.02
  • Prev Close8.95
  • 52 Week High14.34
  • 52 Week High Date05/17/22
  • 52 Week Low5.06
  • 52 Week Low Date01/24/22
  • Market Cap509.86M
  • Shares Out56.09M
  • 10 Day Average Volume0.97M
  • Dividend-
  • Dividend Yield-
  • Beta1.96
  • YTD % Change39.02

RATIOS/PROFITABILITY

  • EPS (TTM)-1.41
  • P/E (TTM)-6.44
  • Fwd P/E (NTM)-12.28
  • EBITDA (TTM)-63.924M
  • ROE (TTM)-102.72%
  • Revenue (TTM)132.41M
  • Gross Margin (TTM)57.44%
  • Net Margin (TTM)-59.35%
  • Debt To Equity (MRQ)152.67%

EVENTS

  • Earnings Date10/31/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Evolus Inc

There is no recent news for this security.

Profile

MORE
Evolus, Inc. is a performance beauty company, which is focused on delivering products in the self-pay aesthetic market. The Company’s first commercial product is Jeuveau, which is an approximately 900 kilodalton (kDa), purified botulinum toxin type A formulation indicated for the temporary improvement in the appearance of moderate to severe glabellar lines, also known as frown lines, in adults. Its primary market is the self-pay aesthetic market, which includes medical...
Vikram Malik
Chairman of the Board
David Moatazedi
President, Chief Executive Officer, Director
Address
520 Newport Center Dr Ste 1200
Newport Beach, CA
92660-7022
United States

Top Peers

SYMBOLLASTCHG%CHG
MCRB
Seres Therapeutics Inc
5.01+0.19+3.94%
SELB
Selecta Biosciences Inc
2.61+0.05+1.95%
NSTG
NanoString Technologies Inc
14.99+0.93+6.61%
ADMA
ADMA Biologics Inc
2.00-0.03-1.48%
ADCT
ADC Therapeutics SA
7.87-0.10-1.25%